We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Drug - Grapefruit Interaction Increasingly Common

By HospiMedica International staff writers
Posted on 10 Dec 2012
The number of drugs that can be risky when taken with grapefruit is on the rise, largely due to the influx of new medications and chemical formulations, according to a new study.

Researchers at Lenox Hill Hospital (New York, NY, USA) reviewed medical literature for articles on grapefruit and drug interaction, as well as reviewing prescribing information for recently approved drugs in Canada. More...
In all, they identified more than 85 drugs that may interact with grapefruit. Of these, the number of drugs that may result in potentially fatal side effects when mixed with grapefruit increased from 17 to 43 during the past four years; this equates to more than six new potentially risky drugs a year. The list includes some statins such as atorvastatin, lovastatin, and simvastatin, some antibiotics, cancer drugs, and cardiovascular medication.

The interaction can occur even if grapefruit is eaten many hours before taking the medication. For example, simvastatin, when taken with a medium glass of grapefruit juice once a day for three days, produced a 330% greater concentration of the drug compared to taking it with just water, which could cause rhabdomyolysis, a life-threatening damage to muscle tissue. With other drugs, just one serving of grapefruit can potentiate the effects, simulating taking multiple doses of the drug. The study was published early online on November 26, 2012, in the Canadian Medical Association Journal.

“If you consume grapefruit juice and take medications, be careful. If you need these drugs and there are not appropriate substitutes, you may need to limit or reduce your consumption of grapefruit juice and products,” said lead author Tara Narula, MD. “Some have more of an effect if you take them in close proximity to drinking grapefruit juice than if you space it out, but there can still be an interaction if you take the pill the night before or 12 hours before consuming grapefruit or grapefruit juice.”

Grapefruit contains furanocoumarins, potentially toxic organic compounds produced by plants as a defense mechanism against various types of predators, ranging from insects to mammals. In humans, the furanocoumarins bergamottin and dihydroxybergamottin are responsible for the "grapefruit juice effect" by affecting the hepatic and intestinal enzyme cytochrome P450 isoform CYP3A4, an enzyme that normally breaks down certain medications in the body. When it is left unchecked, medication levels can grow toxic in the body. Other citrus fruits such as Seville oranges, limes, and pomelos also contain furanocoumarins, but have not been as widely studied.

Related Links:
Lenox Hill Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.